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ABSTRACT
According to the endocrine model of hereditary dizygotic twinning,
high FSH is responsible for multiple ovulation and pregnancy. Our
study explored the underlying neuroendocrine causes.
In a prospective clinical study, we compared the third day of men-
ses parameters of episodic secretion of LH and FSH, the pituitary
response to LHRH, plasma estradiol, and dimeric inhibin A and B in
16 regularly menstruating and 9 postmenopausal mothers of dizy-
gotic twins with a family history of twinning and 14 premenopausal
and 9 postmenopausal controls. Seven of 16 premenopausal mothers
of twins had abnormally high FSH levels of more than 10 IU/L com-
pared with 1/14 in controls (P 5 0.024). In the premenopausal mothers
of twins, mean FSH concentrations (P 5 0.025) and FSH pulse fre-
quency (P 5 0.003) were significantly elevated, whereas FSH pulse
amplitude and FSH response to LHRH were unaltered. For LH, nei-
ther the secretory parameters nor the response to LHRH was differ-
ent. There were no differences between estradiol and inhibin A and
B levels. Postmenopausal mothers of twin and controls did not differ
with respect to the secretory pattern of LH and FSH.
We conclude that under equal ovarian feedback conditions, pre-
menopausal mothers of a dizygotic twin have hyper stimulation by
endogenous FSH caused by neuroendocrine, hypothalamic, or pitu-
itary mechanisms. This is the result of altered responsiveness to
ovarian feedback and/or pituitary or suprapituitary, non-LHRH-like
mechanisms that stimulate pulsatile FSH. (J Clin Endocrinol Metab
83: 481–486, 1998)
NATURAL dizygotic twinning often occurs on a hered-itary basis (1, 2). Furthermore, maternal age above 35
yr carries an increased risk of dizygotic twinning (3). Mul-
tiple follicle growth and subsequent multiple ovulation seem
a logical explanation. Both have been demonstrated in moth-
ers of hereditary dizygotic twins (4, 5). Usually, ongoing
development of one dominant follicle takes place when a
certain threshold in the level of plasma FSH is only margin-
ally exceeded (6, 7). Multiple follicle growth is related to FSH
levels higher than this threshold or to levels exceeding the
threshold for too long a time (8). Milham (9) introduced an
endocrinological model explaining the epidemiological ob-
servations for dizygotic twinning. According to this model,
pituitary gonadotropins such as FSH and LH are responsible
for the increased ovulation in mothers of dizygotic twins.
Several studies have shown increased plasma gonadotropin
levels in mothers of dizygotic twins (10–12).
Our study tested the hypothesis that a pituitary or supra-
pituitary hereditary difference exists that causes increased
FSH levels in mothers of hereditary dizygotic twins. Both LH
and FSH are clearly secreted in a pulsatile fashion during the
early follicular phase (13). Pulsatile LH can be considered a
good representation of the episodic activity of the hypotha-
lamic LHRH pulse generator. Obviously, in cases of elevated
FSH levels, detailed analysis of its episodic secretion, in
concert with that of LH, could potentially reveal responsible
mechanisms. We report here the pulsatile secretion of LH
and FSH and the responsiveness to a test dose of LHRH in
mothers of hereditary dizygotic twins compared with con-
trols. Measurements took place on the third day of menstru-
ation during the luteo-follicular transition of the cycle when
recruitment of new follicles takes place (8). To evaluate the
role of the ovary as a potential cause of differences in go-
nadotropin secretion, the levels of estradiol and dimeric in-
hibin A and B were also measured. Inhibin A, which is
produced by the ovary in the luteal phase, and inhibin B,
which is produced by the ovary in the follicular phase, are
now clearly considered to be of physiological importance in
the regulation of the menstrual cycle because of their selec-
tive negative feedback of FSH secretion (14). In a further
attempt to define ovarian factors in hereditary dizygotic
twinning, episodic gonadotropin secretion was evaluated in
absence of ovarian feedback, i.e. after menopause, in mothers
of twins and controls.
Subjects and Methods
Subjects
The study was approved by the local Committee of Ethics on Research
in Human Subjects. Mothers of dizygotic twins were recruited by means
of an advertisement in a annually published newsletter sent to all vol-
unteers being registered in the Dutch Twin Register. This register is kept
up to date at the division of Psychonomics from the Faculty of Psy-
chology of the Free University of Amsterdam. Volunteering mothers of
twins had to have given birth to spontaneous dizygotic twins of unequal
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sex before the age of 36 yr and had to have had at least one other
dizygotic twin in a first or second degree female relative. They had to
be in good general health without any current medical treatment.
Women with hormonal treatment in the 6 months preceding the study
were excluded. Premenopausal mothers had to have a regular menstrual
cycle varying between 21–35 days in length. Postmenopausal mothers
had to be at least 3 yr after menopause. The control singleton mothers
had to meet the same criteria but with the requirement of having given
birth to at least two singleton pregnancies before the age of 36 yr and
had to be without twins in the family.
Blood sampling
Blood samples were collected on the third day of menstruation in the
premenopausal group. All participants kept a basal body temperature
chart to verify ovulation in the study cycle. In the postmenopausal
group, the blood sampling took place on a convenient working day.
Serial blood samples for LH and FSH determination were taken every
10 min for 6 h via an indwelling catheter with a heparin lock in a
convenient forearm vein. Sampling was always started between 0800–
0900 h. Immediately after the last sample, an LHRH challenge with an
iv injection of 100 mg LHRH (HRF, Wyeth, Hoofddorp, The Netherlands)
followed, and three additional samples were taken after 30, 60, and 90
min for LH and FSH measurement.
Assays
Dimeric LH and FSH were measured in duplicate by means of a
double first monoclonal and second polyclonal antibody immunora-
diometric assay (IRMA-mat BYK-Sangtec Diagnostica GmbH & Co.,
Dietzenbach, Germany) with a lower detection limit of 0.2 IU/L. Ref-
erences for expression of LH and FSH were first International Reference
Preparations 68/40 and second International Reference Preparations
78/549, respectively. LH intraassay coefficients of variation (CV) were
4.3% and 2.4% at the levels of 3 U/L and of 23 U/L, respectively. FSH
intraassay CVs were 3% and 1.8% at levels of 7 U/L and 74 U/L,
respectively. Interassay CVs were below 8% for both gonadotropins. For
each individual, all samples were measured in the same assay for each
hormone.
Inhibin A and B were measured in duplicate with two-site enzyme-
linked immunoassays (Serotec, Oxford, UK) (14, 15). CVs were less than
5% within a plate, and less than 7% between plates of both assays. The
sensitivity was 3 pg/mL for inhibin A and 15 pg/mL for inhibin B. Both
hormones were measured in duplicate. Estradiol was measured by
means of radio immunoassay (Sorin Biomedical, Silage, Italy) with a
lower limit of detection of 18 pmol/L and CVs of less than 5%.
Pulse analysis
The analysis used was a computerized version of a previously de-
veloped and validated method (16, 17). The algorithm is valid for rep-
licate repeated measurements of LH and FSH, with a less than 5% chance
of indication of nonexisting pulses in series of 100 samples taken from
pooled serum. This method is of particular value in detecting episodic
secretion of hormones with relatively long half-lives, because pulses are
indicated when a significant rise occurs without the requirement of a
subsequent decline. Nadirs preceding the pulses are indicated as marker
points in the hormone patterns rather than the pulses themselves.
Statistical analysis
For each subject, the mean concentrations of LH and FSH, the mean
pulse amplitude over the day, and the frequency of LH and FSH pulses
per 6 h were calculated. The maximal gonadotropin increment was taken
as a parameter for the response to the LHRH challenge.
LH and FSH pulses were indicated to have occurred not synchro-
nously when their beginnings were more than 10 min apart (18). From
each subject, the number of FSH pulses that occurred singularly or in
concordance with an LH pulse was estimated, and means per group
were compared.
Hormone levels were transformed logarithmically before statistical
analysis. Student’s t test was used for comparison of means. Linear
regression analysis was performed with the following dependent vari-
ables: mean concentrations, pulse frequencies per 6 h, pulse amplitudes,
and responses to LHRH challenge. Twinning feature and smoking hab-
its, expressed as number of pack years as a potential confounder, (19)
were the independent variables. Fisher’s exact test was used to evaluate
significance of incidence of occurrence of high FSH values. Two- sided
P , 0.05 was considered to indicate statistical significance.
Results
Basic characteristics of study population
We studied 16 premenopausal mothers of dizygotic twins
and 14 controls. Their basic characteristics are summarized
in Table 1. The mothers of twins did not differ from the
controls with respect to age, parity, body mass index, and
time from last delivery. However, they had smoked signif-
icantly more and their menstrual cycle length was 2 days less.
Nine postmenopausal mothers of twins and eight controls
met the inclusion criteria. The two groups did not differ with
respect to any of the basic characteristics (Table 2).
FSH secretion
The pulsatile nature of FSH and LH secretion was clearly
discernible in both groups. Figure 1 shows the patterns of
gonadotropin secretion in two premenopausal mothers of
twins and two controls. Mean 6 sd FSH levels (the overall
average of all 37 samples per subject) of the premenopausal
mothers of a dizygotic twin were 9.8 6 5.5 IU/L, which is
about 65% higher compared with control values of 6.0 6 3.0
IU/L (P 5 0.025). This coincided with a significant increase
(P 5 0.003) in FSH pulse frequency of 4.8 6 1.5 pulses/6 h
compared with 3.0 6 1.5 pulses/6 h (Fig. 2). In mothers of
twins, higher FSH levels were significantly associated with
an increase in FSH pulse frequency (linear regression anal-
ysis: P 5 0.0215). After correction for the differences in smok-
TABLE 1. Baseline characteristics (mean 6 SD) of premenopausal
mothers of dizygotic twins and controls
Characteristic Controls(n 5 14)
Twin mothers
(n 5 16) P
Age (yr) 35.1 6 3 35.9 6 3.4 0.500
Body mass index (kg/m2) 22.2 6 3.9 23.0 6 2.8 0.511
Cycle length (days) 28.4 6 2.7 26.4 6 2.2 0.037
Smoking (no. of pack years) 3.3 6 5.6 7.0 6 8.9 0.051
Days from last delivery 1857 6 1300 1615 6 1153 0.597
Parity 2.2 6 0.4 1.9 6 0.9 0.351
Age at twin delivery (yr) 30.0 6 5.2
TABLE 2. Baseline characteristics (mean 6 SD) of
postmenopausal mothers of dizygotic twins and controls
Characteristic Controls(n 5 8)
Twin mothers
(n 5 9) P
Age (yr) 59.4 6 9.0 55.3 6 6.2 0.311
Body mass
index (kg/m2)
23.6 6 2.6 25.2 6 4.2 0.340
Smoking (no. of
pack years)
4.1 6 5.0 3.1 6 4.8 0.704
Age at
menopause
48.2 6 3.6 47.2 6 4.3 0.609
Years after
menopause
11.1 6 11.4 8.1 6 6.9 0.530
Parity 3.1 6 1.1 3.1 6 1.3 0.981
Age at twin
delivery (yr)
29.1 6 3.6
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ing habits, the tendency for twinning still was shown to be
an independent determinant for elevation of FSH levels and
pulse frequency. In the linear regression model, age and
body mass did not appear to be a determinant of FSH level.
The mean FSH pulse amplitude and the maximum response
to LHRH challenge were not significantly different. Com-
pared with controls (1/14), significantly more mothers of
twins (7/16) had one or more individual FSH values above
10 IU/L (P 5 0.024). In the postmenopausal mothers of twins,
FSH secretory parameters were not different from controls
(Fig. 2).
LH secretion and ovarian feedback
In the premenopausal and postmenopausal mothers of
twins, the parameters for episodic LH secretion did not differ
from controls (Fig. 2). In the premenopausal mothers, mean
plasma levels of 17-b estradiol and dimeric inhibin A
and B levels showed no difference between the two groups
(Table 3).
Copulsatility
The mean number and range of FSH pulses occurring
without a concurrent LH pulse was a mean of 2.19 (range,
0–7) in mothers of twins, which was significantly more com-
pared with controls (mean 0.93; range, 0–4; P 5 0.033). The
number of FSH pulses that had occurred synchronous with
an LH pulse was not significantly different. In the postmeno-
pausal mothers, no differences were observed with respect to
number of individual LH and FSH pulses.
Discussion
In the present study, we attempted to show more precisely
the site of origin of any difference in gonadotropin secretion
related to dizygotic twinning. In line with Milham’s (9)
hypothesis and in agreement with earlier findings by Martin
et al. (10, 11) we observed elevated follicular phase levels of
FSH in mothers with a hereditary history of dizygotic twins.
We found that this is associated with a rise in the FSH pulse
FIG. 1. Examples of secretion pattern and response to LHRH in two mothers of hereditary twins and two mothers of singletons. Solid lines
represent FSH; dashed lines represent LH. , Denote start of an FSH pulse; , indicate LH pulses.
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frequency without any changes in other characteristics of
pulsatile FSH.
Furthermore, we evaluated ovarian feedback by measur-
ing estradiol levels and inhibin A and B to explain the ele-
vated FSH levels. We found no changes in any of these
negative feedback hormones, which is in line with earlier
human studies (5, 10, 11). In addition, in the Booroola sheep
model for dizygotic twinning, which exhibits an autosomal
dominant gene (FecB) associated with elevated FSH levels
and localized to a region homologous to the human chro-
mosome 4, there is no evidence for differences in bioactive
inhibin secretion (20). This argues against diminished neg-
ative ovarian feedback as the primary cause of elevated FSH
levels in mothers of dizygotic twins.
Our observation of no differences in the secretion of FSH
in postmenopausal mothers of twins compared with controls
would nevertheless suggest a role for the ovary. It should be
noted, however, that under postmenopausal conditions, sub-
tle differences in FSH secretion may easily be obscured by the
great hourly and interindividual variability in secretion of
this hormone. Furthermore, it is possible that despite equal
levels of hormones exerting negative feedback as measured
with immunoassays, differences may exist in biological ac-
tivity. However, the inhibin assays that were used only mea-
sured intact dimeric hormone, which correlates well with
biological activity (14). We cannot rule out the possibility that
still unknown ovarian hormones that regulate feedback of
gonadotropin secretion are involved. Specific FSH stimula-
tory substances like activins, which are homodimers of the
b-chains of inhibin but not their binding protein follistatin,
may be involved in the natural rise of FSH in aging women
(21). Others claim however, that activin is not involved in the
gonadal regulation of the menstrual cycle (22). A logical
explanation of our observations would be that differences in
response to gonadal feedback signals are present. This would
favor the pituitary and/or the hypothalamus as the primary
sites involved in altered gonadotropin secretion in mothers
of dizygotic twins.
A difference in FSH moiety that would result in increased
serum half-life, thereby accounting for greater circulating
concentrations in the mothers of twins, does not seem likely,
because in our study the higher FSH levels can be attributed
to a clear increase in the number of pulses. Several obser-
vations rule out an altered activity of the LHRH pulse gen-
erator as the cause of the increase in FSH pulse frequency. In
the first place, the increase only concerned additional FSH
pulses without a simultaneous LH pulse. In the second place,
FSH pulse amplitudes were unaltered and there was no
change in maximal response to LHRH. This makes it unlikely
that an increased pituitary sensitivity to smaller LHRH
pulses has caused the additional FSH pulses. Finally, and
FIG. 2. Means and SD of different parameters of episodic LH (upper panels) and FSH (lower panels) in premenopausal (left side) and post-
menopausal (right side) mothers of dizygotic twins (solid bars) and controls (open bars). *, P 5 0.025; **, P 5 0.003.
TABLE 3. Characteristic (mean 6 SD) of ovarian feedback on
cycle day 3 in premenopausal mothers of dizygotic twins (n 5 16)
and controls (n 5 14)
Characteristic Controls Twin mothers P
Estradiol (pmol/L) 140 6 82 192 6 170 0.350
Inhibin A (pg/mL) 5.4 6 2.8 4.7 6 2.3 0.413
Inhibin B (pg/mL) 77.8 6 42.6 75.6 6 46.0 0.901
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probably most convincing, is our observation that none of the
dynamic parameters of the LH secretion were different in the
mothers of the twins.
For the initiation and maintenance of FSH secretion, pul-
satile LHRH is an absolute prerequisite (23). There are in-
dications that once FSH synthesis has started, spontaneous
release by the pituitary may occur without LHRH stimula-
tion. In particular, this part of FSH secretion is under the
control of negative feedback through inhibin (24). In addition
to this autonomous FSH secretion, pulsatile FSH secretion
occurs in association with exogenous or endogenous LHRH
pulses (25, 26), but the link between LHRH and FSH pulses
is much less than between LHRH and LH pulses. The oc-
currence of single FSH pulses in earlier studies in postmeno-
pausal women (18, 25, 27) without a concomitant LH pulse,
indicates the presence of LHRH-independent factors gov-
erning episodic FSH secretion. This is also supported by the
recent observations in sheep of clear FSH pulses in jugular
vein blood without significant LHRH elevations in serially
sampled blood from pituitary portal blood vessels (28). Al-
tered activity of such factors are probably involved in the
increased number of FSH pulses in mothers of twins. There
are several possibilities for the nature of this(ese) factor(s). In
the first place, spontaneous pituitary FSH secretion may
occur in temporary bursts independent of any releasing fac-
tor. However, there are no data available that would support
such a secretory mechanism. Alternatively, mothers of dizy-
gotic twins may have genes that are activated that code for
a still-putative separate FSH releasing hormone (29, 30), or
they may carry mutations in the gene coding for LHRH,
resulting in synthesis of an LHRH- like peptide preferably
inducing secretion of FSH over LH (31).
In our view, it seems valid to assume that an hereditary
trait of having dizygotic twins is the result of endogenous
hyperstimulation by FSH in a significant proportion of moth-
ers. A high proportion of mothers of twins in this study had
one or more FSH values over 10 IU/L. Within the specifi-
cations of the assay that was used in this study, this obser-
vation is usually associated with incipient ovarian failure
when observed in regularly menstruating women. This is
thought to be caused by a diminished ovarian reserve (32).
There are indications that being a mother of a dizygotic twin
(either on an hereditary or nonhereditary basis) is a risk for
earlier menopause (33). In the present study however, the
postmenopausal mothers of hereditary dizygotic twins did
not differ with controls in age at menopause. This might have
been the result of undetectable results because of small sam-
ple size, but it may also indicate that incipient ovarian failure
and hereditary dizygotic twinning are different entities. On
the other hand, the natural rise of follicular phase FSH levels,
as observed in general after 30 yr of age, may be the under-
lying cause of the risk of nonhereditary dizygotic twinning
(3) with increased maternal age. Somewhat to our surprise,
we could not show a relation between age and FSH. Probably
a substantially larger number of subjects are needed to find
these differences. Anyway, it should be noted that not all
patients with high FSH levels in the early follicular phase
should be considered to have premature incipient ovarian
failure.
In conclusion, the endocrine hypothesis of an elevated FSH
in hereditary dizygotic twinning seems valid. Our results
favor pituitary- or LHRH-independent factors from higher
regions of the brain leading to more FSH and hereby causing
dizygotic twinning.
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